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ABSTRACT Today, next-generation whole-genome sequencing (WGS) is increasingly
used to determine the genetic relationships of bacteria on a nearly whole-genome
level for infection control purposes and molecular surveillance. Here, we conducted
a multicenter ring trial comprising ﬁve laboratories to determine the reproducibility
and accuracy of WGS-based typing. The participating laboratories sequenced 20
blind-coded Staphylococcus aureus DNA samples using 250-bp paired-end chemistry
for library preparation in a single sequencing run on an Illumina MiSeq sequencer.
The run acceptance criteria were sequencing outputs 5.6 Gb and Q30 read quality
scores of 75%. Subsequently, spa typing, multilocus sequence typing (MLST), ribo-
somal MLST, and core genome MLST (cgMLST) were performed by the participants.
Moreover, discrepancies in cgMLST target sequences in comparisons with the in-
cluded and also published sequence of the quality control strain ATCC 25923 were
resolved using Sanger sequencing. All ﬁve laboratories fulﬁlled the run acceptance
criteria in a single sequencing run without any repetition. Of the 400 total possible
typing results, 394 of the reported spa types, sequence types (STs), ribosomal STs
(rSTs), and cgMLST cluster types were correct and identical among all laboratories;
only six typing results were missing. An analysis of cgMLST allelic proﬁles corrobo-
rated this high reproducibility; only 3 of 183,927 (0.0016%) cgMLST allele calls were
wrong. Sanger sequencing conﬁrmed all 12 discrepancies of the ring trial results in
comparison with the published sequence of ATCC 25923. In summary, this ring trial
demonstrated the high reproducibility and accuracy of current next-generation
sequencing-based bacterial typing for molecular surveillance when done with nearly
completely locked-down methods.
KEYWORDS whole-genome sequencing, ring trial, interlaboratory reproducibility,
cgMLST, molecular subtyping
Today, next-generation sequencing (NGS) is increasingly used to determine thegenetic relationships of bacteria on a nearly whole-genome level for infection
control purposes and phylogenetic studies. In a shotgun approach, fragmented bac-
terial DNA is usually sequenced in a highly parallel way, resulting in millions of short
reads (up to 400 nucleotides in length) that are either compared to an ideally closely
related reference genome (mapping) or are assembled de novo for the subsequent
extraction of genomic information. Currently, two different approaches, based on single
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nucleotide polymorphisms (SNPs) (1, 2) or allelic changes (core genome multilocus
sequence typing [cgMLST]) (3–5), are used to extract whole-genome sequencing (WGS)
information for subsequently displaying the genotypic relationship.
For continuous infection control surveillance, typing methods should be highly
reproducible, ideally generating identical typing results across different laboratories.
Previously, we demonstrated that this is the case for spa typing that is based on the
DNA sequence determination of a repetitive region of the protein A gene (spa) of
Staphylococcus aureus using Sanger sequencing (6). For NGS data, it is known that
different sequencing technologies exhibit different error characteristics at the read level
(7, 8). Moreover, the analysis pipelines, including assemblers and analytical parameters,
can inﬂuence the ﬁnal typing results (7, 9, 10). However, it is unknown how reproduc-
ible the overall process of WGS-based bacterial typing is when applied in a multicenter
study.
Therefore, we investigated the reproducibility and accuracy of microbial WGS-based
typing, employing an international ring trial of ﬁve laboratories in three European
countries (Denmark, Germany, and The Netherlands).
RESULTS AND DISCUSSION
All ﬁve laboratories met the minimum run quality criteria in a single run without
repetition (Table 1). Mean sample coverage was 131-fold. However, the coverage per
sample varied markedly between 29- and 256-fold, but only samples NGSRT07C1 and
NGSRT16C3 exhibited coverages of 75-fold (see Table S1 in the supplemental mate-
rial). Also, the mean N50 assembly metric parameters differed markedly, whereas the
mean percentages of called cgMLST targets were quite even between the laboratories
(Table 1). Sample N50 values and percentages of called cgMLST targets were consis-
tently low in samples with 75-fold coverage (see Table S1). All of the reported spa
types, sequence types (STs), ribosomal STs (rSTs), and cluster types (CTs) were identical
(see Table S1). Also, Sanger sequencing-based spa typing and BIGSdb revealed identical
spa types, STs, and rSTs. Only in the two low-coverage samples, the rST, CT, and also the
ST for NGSRT16C3, were not assigned. Moreover, in sample NGSRT13C3, the sequence
of the 16 repeats containing spa type t032 was not determined.
In-depth analysis of the up to 1,861 reported cgMLST genes per sample demon-
strated that the majority of isolates shared identical allelic proﬁles (Fig. 1). A comparison
with the controls (NGSRT06-15), which exhibited no deviation, further corroborated this
high reproducibility independent from DNA extraction. Samples NGSRT11C1 and
NGSRT11C4 varied in one gene (hypothetical protein, SACOL0424), very likely due to a
misassembly at the end of the gene. Also, for NGSRT02C1, a wrong allele was called in
SACOL2642 (hypothetical protein) due to a low local coverage of 2-fold. These ﬁndings
are in line with those of a previous study, where an N50 plateau effect for Illumina data
was noted above a threshold of 75-fold average coverage (7).
In total, of 183,927 cgMLST allele calls, only 3 (0.0016%) were wrong, resulting in an
average of 0.03 wrong alleles per sample. This low error rate does not signiﬁcantly
TABLE 1 Summary of sequencing run characteristics and cumulative analysis results from the ﬁve participating laboratories
Laboratory
designation













Mean % called cgMLST
targets (SD, range)
C1 935 8.6 89.9 225 129 (27, 43–170) 56,620 97.5 (5.7, 73.3–99.6)
C2 715 6.7 92.2 237 106 (17, 76–144) 153,228 99.2 (0.4, 98.0–99.8)
C3 1,297 10.6 87.7 238 169 (54, 29–256) 253,745 98.9 (2.2, 89.7–100)
C4 878 8.2 88.4 221 123 (16, 98–164) 101,873 99.2 (0.4, 98.5–99.9)
C5 1,247 10.8 78.1 180 129 (24, 86–187) 225,594 99.3 (0.3, 98.7–100)
Total mean 1,014 9.0 87.3 220 131 (27, 66–184) 158,212 98.8 (1.8, 91.6–99.9)
aRead lengths after Illumina base calling and adapter removal.
bSD, standard deviation.
cCoverage is calculated for an S. aureus genome size of 2.8 Mb.
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affect the ruling in or out of samples during outbreak investigations (11) and ensures
high intra- and interlaboratory reproducibilities.
To control the accuracy, the 1,861 cgMLST target sequencing results from sample
NGSRT16, i.e., ATCC 25923, which were identical for all ﬁve laboratories (Fig. 1), were
compared with the published genome sequence of this strain (NZ_CP009361) revealing
12 single nucleotide polymorphisms (SNPs) (see Table S2). Suitable primers for ampli-
fying and subsequent Sanger sequencing were designed for the 12 regions spanning
these SNPs (see Table S2) and conﬁrmed that all 12 SNPs were correctly determined
during the ring trial. Most likely, the discrepancy with the published sequence can be
explained by microevolutionary events that occurred during the freezing, thawing, and
repeated cultivation of this strain, which was originally isolated from a clinical specimen
in 1945 (12). Similar effects were already previously detected (7).
Our study comprises four limitations. First, we sent only DNA instead of living
organisms to the ﬁve laboratories, and thereby did not test the inﬂuence of DNA
extraction methods. The results from the 10 controls analyzed in parallel in the ring trial
organizer’s laboratory indicated that this might be of minor importance, as long as
high-quality DNA is deployed. Second, we only compared data from one type of
FIG 1 Minimum-spanning tree illustrating the comparison of cgMLST results from the 20 S. aureus isolates sent to ﬁve laboratories (C1
to C5) in a blinded fashion. Each circle represents a single genotype, i.e., an allelic proﬁle based on up to 1,861 target genes (23) present
in the isolates with the “pairwise ignoring missing values” option turned on in the SeqSphere software during comparison. The circles
are named with the sample ID(s) colored by the participating laboratory, and the sizes are proportional to the number of isolates with
an identical genotype. The numbers on connecting lines display the number of differing alleles between the connected genotypes. The
control samples colored in white originated from independent cultivations and DNA extractions of samples NGSRT06 to NGSRT15.
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sequencing machine and one type of sequencing chemistry. However, there is evidence
from the literature that results from a single laboratory are not signiﬁcantly biased by
the sequencing machine nor by the sequencing chemistry (13, 14). Third, all of the ring
trial participants used the same software for analysis. To partially address this issue, we
used another tool to verify ST and rST assignment and demonstrate reproducibility
across different tools. The Global Microbial Identiﬁer (GMI) wet- and dry-laboratory
proﬁciency test attempts to overcome such limitations, but is challenged by making
in-depth comparisons of the heterogeneous results (15). Finally, the accuracy was only
determined for cgMLST targets. In accordance with recent practices in public health
and clinical microbiology (16), the intergenic regions in particular were not controlled
here.
In summary, with the shown high reproducibility and accuracy of WGS-based
microbial typing when using a standardized methodology, our study provides the basis
for a proﬁciency testing program, which is one crucial component for ensuring the
quality of next-generation sequencing in clinical laboratory practice (17).
MATERIALS AND METHODS
Twenty Staphylococcus aureus DNA samples (NGSRT01 to NGSRT20) (Table 2), selected from a diverse
collection of isolates (livestock-associated, community-/hospital-acquired methicillin-susceptible and
-resistant S. aureus from sporadic cases and outbreaks, and a quality control strain), along with duplicates
to assess intralaboratory reproducibility, were distributed in a blind-coded manner to the ﬁve partici-
pating laboratories. DNA samples were prepared using the MagAttract HMW DNA kit (Qiagen, Hilden,
Germany) in accordance with the manufacturer’s instructions with the addition of 120 U lysostaphin
(Sigma, Taufkirchen, Germany) to lyse methicillin-resistant S. aureus (MRSA). In addition, the laboratories
received a protocol (supplemental material) for performing a single sequencing run on an Illumina MiSeq
sequencer using the Nextera XT library preparation kit and the 250-bp paired-end sequencing chemistry
version 2 (Illumina, San Diego, CA, USA). Sequencing indices from the Nextera XT index kit were used for
multiplexing; participants were free to choose any index combination for the samples. The run accep-
tance criteria were a sequencing output 5.6 Gb (to achieve an average sequencing coverage of
100-fold for the 20 samples with genome sizes of 2.8 Mb) and a Q30 read quality score of 75%.
Otherwise, the sequencing run had to be repeated. SeqSphere software version 2.4 or higher (Ridom
GmbH, Münster, Germany) run on a Microsoft Windows operating system was used with default
parameters for quality trimming, de novo assembly, and allele calling. Speciﬁcally, reads were trimmed
at their 5=- and 3=-ends until an average base quality of 30 was reached in a window of 20 bases and
subsequently down-sampled to 120-fold coverage. De novo assembly was performed using the incor-
porated Velvet tool version 1.1.04 and a SeqSphere speciﬁc k-mer optimization procedure (18).
TABLE 2 Characteristics of the 20 human S. aureus isolates that were sent as DNA samples to the ﬁve participating laboratories in a
blinded fashion and used as controls
Sample ID
Spa type (based on
Sanger sequencing) Comment/referenceRing trial Original
NGSRT01 00468 t011 Livestock-associated MRSA
NGSRT02 00551 t011 Livestock-associated MRSA, identical cgMLST genotype as NGSRT01
NGSRT03 01346 t011 Livestock-associated MRSA
NGSRT04 01354 t010 Classical hospital-acquired MRSA
NGSRT05 01360 t011 Livestock-associated MRSA, identical cgMLST genotype as NGSRT03
NGSRT06a 02180 t002 Central European community-acquired PVLb-positive MRSA
NGSRT07a 02482 t008 US typical community-acquired PVL-positive MRSA
NGSRT08a 02560 t044 Central European community-acquired PVL-positive MRSA
NGSRT09a 02638 t012 Classical hospital-acquired MRSA
NGSRT10a 02786 t843 mecC-positive MRSA
NGSRT11a 02949 t843 mecC-positive MRSA
NGSRT12a 02994 t003 Classical hospital-acquired MRSA
NGSRT13a 03039 t032 Classical hospital-acquired MRSA
NGSRT14a COL t008 MRSA strain COL
NGSRT15a COL t008 Duplicate of MRSA reference strain COL
NGSRT16 ATCC 25923 t021 MSSA quality control strain ATCC 25923
NGSRT17 P1 t001 Isolate P1 from reference 23
NGSRT18 P3 t001 Isolate P3 from reference 23
NGSRT19 P4 t001 Isolate P4 from reference 23, identical cgMLST genotype as NGSRT18
NGSRT20 P12 t001 Isolate P12 from reference 23
aThese samples were separately cultivated, and DNA was extracted and sequenced as controls.
bPVL, Panton-Valentine leukocidin.
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SeqSphere searched the deﬁned genes using BLAST (19) with parameters described previously (20). In
addition, the genes were assessed for quality, i.e., the absence of frameshifts and ambiguous nucleotides.
A gene was called only if all above-mentioned criteria were met. Thus, determined spa types (10), MLST
sequence types (ST) (21), ribosomal MLST types (rST) (22), cgMLST cluster types (CT), and allelic proﬁles
of the 1,861 cgMLST genes (23) were reported to A.M., the ring trial organizer.
In parallel, ST and rST were also determined from the assembly contigs using the BIGSdb system (21,
22, 24). Moreover, spa typing data using Sanger sequencing were available for all isolates (Table 2).
Furthermore, 10 strains (NGSRT06 to NGSRT15; in the following-named control) were separately culti-
vated, and DNA was extracted and sequenced in the ring trial organizer’s laboratory. For detailed analysis
and visualization, a minimum-spanning tree based on the reported cgMLST allelic proﬁles was con-
structed using SeqSphere with the option “pairwise ignoring missing values” turned on. Finally, as we
had included as NGSRT16 the well-known quality control strain ATCC 25923 that was recently completely
sequenced (12), we determined whether potential discrepancies were due to NGS sequencing errors
during the ring trial. Discrepancies that were detected between the published sequence (NZ_CP009361)
and the ring trial data from all participants were further analyzed by bidirectional Sanger sequencing
from the same DNA that was also sent to the participants. For further conﬁrmatory Sanger sequencing,
ﬂanking regions of approximately 250 nucleotides up- and downstream of the detected discrepancies
were extracted from the genome sequence, and primers were designed using the NCBI Primer-BLAST
service (25). The ampliﬁed fragments were puriﬁed and Sanger sequenced as described previously (26).
The resulting chromatogram ﬁles were also analyzed using the SeqSphere software.
Accession number(s). Raw reads are deposited at European Nucleotide Archive (ENA) under study
accession number PRJEB15231.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/
JCM.02242-16.
TEXT S1, PDF ﬁle, 0.4 MB.
DATA SET S1, XLSX ﬁle, 0.8 MB.
DATA SET S2, XLSX ﬁle, 0.01 MB.
ACKNOWLEDGMENTS
This study was funded by the European Community’s Seventh Framework Program
(grant FP7/2007-2013 to A.M., T.K., S.N., and D.H.) under grant no. 278864 in the
framework of the European Union Patho-NGen-Trace project and the German Center
for Infection Research (DZIF to S.N.).
We thank I. Höﬁg and A. Schultes (Münster), E. Raangs (Groningen), and J. Zallet
and V. Mohr (Borstel) for their help with library preparation, sequencing, and data
analysis.
D.H. is one of the developers of the Ridom SeqSphere software mentioned in the
article, which is a development of the company Ridom GmbH (Münster, Germany) that
is partially owned by him. The other authors have declared no conﬂicts of interest.
REFERENCES
1. Köser CU, Holden MT, Ellington MJ, Cartwright EJ, Brown NM, Ogilvy-
Stuart AL, Hsu LY, Chewapreecha C, Croucher NJ, Harris SR, Sanders M,
Enright MC, Dougan G, Bentley SD, Parkhill J, Fraser LJ, Betley JR,
Schulz-Trieglaff OB, Smith GP, Peacock SJ. 2012. Rapid whole-genome
sequencing for investigation of a neonatal MRSA outbreak. N Engl J Med
366:2267–2275. https://doi.org/10.1056/NEJMoa1109910.
2. Aanensen DM, Feil EJ, Holden MT, Dordel J, Yeats CA, Fedosejev A,
Goater R, Castillo-Ramirez S, Corander J, Colijn C, Chlebowicz MA,
Schouls L, Heck M, Pluister G, Ruimy R, Kahlmeter G, Ahman J, Matuschek
E, Friedrich AW, Parkhill J, Bentley SD, Spratt BG, Grundmann H, Euro-
pean SRL Working Group. 2016. Whole-genome sequencing for routine
pathogen surveillance in public health: a population snapshot of inva-
sive Staphylococcus aureus in Europe. mBio 7:e00444-16.
3. Mellmann A, Harmsen D, Cummings CA, Zentz EB, Leopold SR, Rico A,
Prior K, Szczepanowski R, Ji Y, Zhang W, McLaughlin SF, Henkhaus JK,
Leopold B, Bielaszewska M, Prager R, Brzoska PM, Moore RL, Guenther S,
Rothberg JM, Karch H. 2011. Prospective genomic characterization of the
German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid
next generation sequencing technology. PLoS One 6:e22751. https://
doi.org/10.1371/journal.pone.0022751.
4. Maiden MC, Jansen van Rensburg MJ, Bray JE, Earle SG, Ford SA, Jolley
KA, McCarthy ND. 2013. MLST revisited: the gene-by-gene approach to
bacterial genomics. Nat Rev Microbiol 11:728–736. https://doi.org/
10.1038/nrmicro3093.
5. Kohl TA, Diel R, Harmsen D, Rothgänger J, Walter KM, Merker M, Weniger
T, Niemann S. 2014. Whole-genome-based Mycobacterium tuberculosis
surveillance: a standardized, portable, and expandable approach. J Clin
Microbiol 52:2479–2486. https://doi.org/10.1128/JCM.00567-14.
6. Aires-de-Sousa M, Boye K, de Lencastre H, Deplano A, Enright MC,
Etienne J, Friedrich AW, Harmsen D, Holmes A, Huijsdens X, Kearns A,
Mellmann A, Meugnier H, Rasheed JK, Spalburg E, Strommenger B,
Struelens MJ, Tenover FC, Thomas J, Vogel U, Westh H, Xu J, Witte W.
2006. High interlaboratory reproducibility of DNA sequence-based typ-
ing of bacteria in a multicenter study. J Clin Microbiol 44:619–621.
https://doi.org/10.1128/JCM.44.2.619-621.2006.
7. Jünemann S, Sedlazeck FJ, Prior K, Albersmeier A, John U, Kalinowski J,
Mellmann A, Goesmann A, von Haeseler A, Stoye J, Harmsen D. 2013.
Updating benchtop sequencing performance comparison. Nat Biotech-
nol 31:294–296. https://doi.org/10.1038/nbt.2522.
8. Loman NJ, Misra RV, Dallman TJ, Constantinidou C, Gharbia SE, Wain J,
Pallen MJ. 2012. Performance comparison of benchtop high-throughput
sequencing platforms. Nat Biotechnol 30:434–439. https://doi.org/
10.1038/nbt.2198.
9. Jünemann S, Prior K, Albersmeier A, Albaum S, Kalinowski J, Goesmann
Mellmann et al. Journal of Clinical Microbiology











A, Stoye J, Harmsen D. 2014. GABenchToB: a genome assembly bench-
mark tuned on bacteria and benchtop sequencers. PLoS One 9:e107014.
https://doi.org/10.1371/journal.pone.0107014.
10. Bletz S, Mellmann A, Rothgänger J, Harmsen D. 2015. Ensuring back-
wards compatibility: traditional genotyping efforts in the era of whole
genome sequencing. Clin Microbiol Infect 21:347.e1–347.e4. https://
doi.org/10.1016/j.cmi.2014.11.005.
11. Mellmann A, Bletz S, Böking T, Kipp F, Becker K, Schultes A, Prior K,
Harmsen D. 2016. Real-time genome sequencing of resistant bacteria
provides precision infection control in an institutional setting. J Clin
Microbiol 54:2874–2881. https://doi.org/10.1128/JCM.00790-16.
12. Treangen TJ, Maybank RA, Enke S, Friss MB, Diviak LF, Karaolis DK, Koren
S, Ondov B, Phillippy AM, Bergman NH, Rosovitz MJ. 2014. Complete
genome sequence of the quality control strain Staphylococcus aureus
subsp. aureus ATCC 25923. Genome Announc 2:piie01110-14. https://
doi.org/10.1128/genomeA.01110-14.
13. Harris SR, Torok ME, Cartwright EJ, Quail MA, Peacock SJ, Parkhill J. 2013.
Read and assembly metrics inconsequential for clinical utility of whole-
genome sequencing in mapping outbreaks. Nat Biotechnol 31:592–594.
https://doi.org/10.1038/nbt.2616.
14. Kaas RS, Leekitcharoenphon P, Aarestrup FM, Lund O. 2014. Solving the
problem of comparing whole bacterial genomes across different se-
quencing platforms. PLoS One 9:e104984. https://doi.org/10.1371/
journal.pone.0104984.
15. Global Microbial Identiﬁer. 2016. GMI proﬁciency test report. http://
www.globalmicrobialidentiﬁer.org/Workgroups/GMI-Proﬁciency-Test-
Reports. Accessed 5 Nov 2016.
16. Jackson BR, Tarr C, Strain E, Jackson KA, Conrad A, Carleton H, Katz LS,
Stroika S, Gould LH, Mody RK, Silk BJ, Beal J, Chen Y, Timme R, Doyle M,
Fields A, Wise M, Tillman G, Deﬁbaugh-Chavez S, Kucerova Z, Sabol A,
Roache K, Trees E, Simmons M, Wasilenko J, Kubota K, Pouseele H,
Klimke W, Besser J, Brown E, Allard M, Gerner-Smidt P. 2016. Implemen-
tation of nationwide real-time whole-genome sequencing to enhance
listeriosis outbreak detection and investigation. Clin Infect Dis 63:
380–386. https://doi.org/10.1093/cid/ciw242.
17. Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, Lu F,
Lyon E, Voelkerding KV, Zehnbauer BA, Agarwala R, Bennett SF, Chen B,
Chin EL, Compton JG, Das S, Farkas DH, Ferber MJ, Funke BH, Furtado
MR, Ganova-Raeva LM, Geigenmuller U, Gunselman SJ, Hegde MR, John-
son PL, Kasarskis A, Kulkarni S, Lenk T, Liu CS, Manion M, Manolio TA,
Mardis ER, Merker JD, Rajeevan MS, Reese MG, Rehm HL, Simen BB,
Yeakley JM, Zook JM, Lubin IM. 2012. Assuring the quality of next-
generation sequencing in clinical laboratory practice. Nat Biotechnol
30:1033–1036. https://doi.org/10.1038/nbt.2403.
18. Zerbino DR, Birney E. 2008. Velvet: algorithms for de novo short read
assembly using de Bruijn graphs. Genome Res 18:821–829. https://
doi.org/10.1101/gr.074492.107.
19. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local
alignment search tool. J Mol Biol 215:403–410. https://doi.org/10.1016/
S0022-2836(05)80360-2.
20. Ruppitsch W, Pietzka A, Prior K, Bletz S, Fernandez HL, Allerberger F,
Harmsen D, Mellmann A. 2015. Deﬁning and evaluating a core genome
multilocus sequence typing scheme for whole-genome sequence-based
typing of Listeria monocytogenes. J Clin Microbiol 53:2869–2876. https://
doi.org/10.1128/JCM.01193-15.
21. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. 2000. Multilocus
sequence typing for characterization of methicillin-resistant and
methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol
38:1008–1015.
22. Jolley KA, Bliss CM, Bennett JS, Bratcher HB, Brehony C, Colles FM,
Wimalarathna H, Harrison OB, Sheppard SK, Cody AJ, Maiden MCJ. 2012.
Ribosomal multilocus sequence typing: universal characterization of
bacteria from domain to strain. Microbiology 158:1005–1015. https://
doi.org/10.1099/mic.0.055459-0.
23. Leopold SR, Goering RV, Witten A, Harmsen D, Mellmann A. 2014.
Bacterial whole-genome sequencing revisited: portable, scalable, and
standardized analysis for typing and detection of virulence and antibi-
otic resistance genes. J Clin Microbiol 52:2365–2370. https://doi.org/
10.1128/JCM.00262-14.
24. Jolley KA, Maiden MC. 2010. BIGSdb: Scalable analysis of bacterial ge-
nome variation at the population level. BMC Bioinformatics 11:595.
https://doi.org/10.1186/1471-2105-11-595.
25. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden TL. 2012.
Primer-BLAST: a tool to design target-speciﬁc primers for polymerase
chain reaction. BMC Bioinformatics 13:134. https://doi.org/10.1186/1471
-2105-13-134.
26. Jenke C, Leopold SR, Weniger T, Rothgänger J, Harmsen D, Karch H,
Mellmann A. 2012. Identiﬁcation of intermediate in evolutionary model
of enterohemorrhagic Escherichia coli O157. Emerg Infect Dis 18:
582–588.
WGS-Based Ring Trial Conﬁrms High Reproducibility Journal of Clinical Microbiology




ay 22, 2017 by University of G
roningen
http://jcm.asm.org/
D
ow
nloaded from
 
